Matthew Gline
CEO & DirectorMr. Matthew Gline, also known as Matt, is Independent Director of Arbutus Biopharma Corporation from February 25, 2025. Mr. Gline, also known as Matt, is Chief Executive Officer of Roivant Sciences Ltd. since January 26, 2021 and its Director since September 30, 2021. He has been Chief Executive Officer of Roivant Sciences, Inc. since January 2021 and serves as its Treasurer. Mr. Gline served as Chief Financial Officer of Roivant Sciences, Inc. since March 2016 to January 2021. He served as Senior Vice President of Finance and Business Operations at Roivant Sciences, Inc. since joining in March 2016. From April 2014 to March 2016, he served as a Vice President at Goldman Sachs, Fixed Income Digital Structuring, where he focused on technology and data strategy. Prior to Goldman Sachs, from May 2012 to April 2014, Mr. Gline was a co-founder of Fourthree, Inc. From September 2008 to May 2012, he served as Vice President at Barclays Investment Bank, Enterprise Risk Management Advisory, where he provided analysis for corporate clients related to capital markets access for financing and risk management. Prior experience also includes serving as an Associate at Lehman Brothers, Global Finance Analytics from 2007 to 2008 and an Analyst at Goldman Sachs, Investment Banking Strategies from 2006 to 2007. He serves as a Director of Sumitovant Biopharma Ltd. He served as Director of Urovant Sciences Ltd. since July 2018. Mr. Gline earned his B.A. in Physics (cum laude) from Harvard College in 2006.
Positions
- Company NameRoivant Sciences Ltd.Stock CodeROIVPositionCEO & Director
- Company NameArbutus Biopharma CorporationStock CodeABUSPositionIndependent DirectorColleagues
- LALindsay AndroskiPresident, CEO & Chairman
- TNTuan NguyenChief Financial Officer
- AJAndrew J. SungGeneral Counsel
- RHR. Hector Mackay-DunnCorporate Secretary
- WTWilliam T. SymondsChairman of Scientific Advisory Board
- RARobert Alan BeardsleyIndependent Director
- MGMatthew GlineIndependent Director
- JBJoseph BishopIndependent Director
